Pharmaceutical firm Pfizer has turned to Apple Vision Pro to make an experience that's meant to help cancer patients ...

Pfizer’s PFE R&D pipeline is becoming an increasingly important part of the investment story as the company is trying to ...

PFE's oncology growth is led by Padcev, while a broad pipeline and label expansions aim to fuel longer-term gains.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

BioNTech's colorectal cancer vaccine just collapsed in a Phase 2 trial, dragging Moderna down with it despite last week's ...

Pfizer has rolled out detailed trial data suggesting Tukysa could be part of a new first-line treatment to delay the progression of HER2-positive breast cancer. The current standard of care for the ...

Add Yahoo as a preferred source to see more of our stories on Google. A logo of Pfizer at the company’s booth at the 8th China International Import Expo (CIIE) in Shanghai, China, November 6, ...

Pfizer (PFE) announced on Tuesday that its colorectal cancer therapy, Braftovi, as part of a combination regimen, improved patient survival, reaching a key secondary endpoint in a late-stage trial.

Pfizer PFE is one of the largest and most successful drugmakers in oncology. It boasts a strong portfolio of approved cancer medicines as well as a robust pipeline of cancer candidates with a focus on ...

President William Ruto announces major cancer medicine price cuts after a Pfizer-KEMSA deal, with some treatment costs ...

Opevesostat (Merck). A first-in-class CYP11A1 inhibitor that shuts down androgen production at its source, opevesostat is in two phase 3 trials, OMAHA-003 and OMAHA-004, for metastatic ...